Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

R&D Platform and Pipeline Presentation

15 Aug 2017 07:00

RNS Number : 9748N
Plant Impact PLC
15 August 2017
 

 

For immediate release

 

15 August 2017

 

RNS Reach

Plant Impact Plc

("Plant Impact" or the "Group")

 

Research & Development Platform and Pipeline Presentation

 

Plant Impact plc (AIM: PIM), a leader in research and development in crop enhancement products that growers can rely on to improve the yield and quality of crops, is pleased to publish the first presentation on its research and development ("R&D") platform and pipeline. The full presentation can be found at

www.plantimpact.com/investors

 

The Group's R&D platform is highly differentiated within the emerging crop enhancement sector and is focused on bringing products to market over the next 5 years, with the first pipeline product expected to launched by 2020. The platform begins with an understanding of key yield-limiting physiological and biochemical plant responses. It then prioritises soybean and wheat as model dicot and monocot crops to enable future diversification into other crops such as cotton and corn, and utilises novel synthetic and small molecule chemistry. This methodology generates targeted foliar and seed treatment products.

 

The R&D presentation sets out the following:

 

· Industry - the case for crop enhancement and the current landscape

· Business - structure and history (with an R&D focus)

· Research and technology - platform design, screening process and the case for chemistry

· Pipeline and products - pipeline stages, case studies and focus areas

· Markets - activity overviews and case studies for key markets

· Financial model - corporate value streams, indicative peak annual sales opportunity for pipeline products and an explanation of revenue streams included/excluded from external guidance

· Market estimates (appendix) - methodology used to estimate the indicative market sizes for R&D focus areas

 

Plant Impact believes that crop enhancement will grow to be a significant sector within the chemical and biological farming inputs market, playing a key role in sustainably improving food security worldwide by using new technologies to help growers improve global crop yields.

 

John Brubaker, CEO, said: "Growth and innovation in the crop enhancement sector is accelerating more rapidly than ever before and at Plant Impact we are proud to be at the forefront of R&D advances in synthetic and small molecule chemistry. This is our first R&D presentation; it establishes a new level of clarity on our pipeline and it will be updated regularly. I would like to thank our shareholders for their continued support."

 

 

For further information, contact:

 

Plant Impact

John Brubaker, Chief Executive Officer Tel: +44(0) 1582 465 540

Richard Amos, Chief Financial Officer

Ailish Tracy, Global Communications Manager

www.plantimpact.com

 

Peel Hunt - Nominated Advisor and Broker

Adrian Trimmings Tel: +44 (0) 207 418 8900

George Sellar

 

Buchanan

Mark Court Tel: +44(0) 20 7466 5000

Jamie Hooper

Sophie Cowles

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFETTAISLID
Date   Source Headline
31st May 20118:30 amRNSTotal Voting Rights
24th May 20117:05 amRNS£2.05 million cash subscription by Arysta
24th May 20117:00 amRNSTrading update
6th Apr 20117:00 amRNSRule 17 disclosure
30th Mar 20118:30 amRNSHolding(s) in Company
11th Mar 20117:00 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSAppointment of new Chairman
30th Dec 20107:00 amRNSDirector/PDMR Shareholding
16th Dec 20109:50 amRNSHolding(s) in Company
6th Dec 20107:00 amRNSHalf Yearly Report
24th Nov 201012:00 pmRNSHolding(s) in Company
18th Nov 20107:00 amRNSGrant of product registrations in Brazil
17th Nov 20107:00 amRNSDistribution and evaluation agreement
19th Oct 201010:30 amRNSHolding(s) in Company
23rd Sep 20107:00 amRNSEvaluation, Development and Distribution Agreement
26th Aug 201011:05 amRNSResult of AGM
25th Aug 20107:00 amRNSField Trials with Syngenta
12th Aug 20107:00 amRNSUpdated trial results
9th Aug 20107:00 amRNSGrant of Awards under LTIP and Share Options
5th Aug 20105:00 pmRNSPosting Annual Report and Accounts and AGM Notice
8th Jul 20102:20 pmRNSAppointment
14th Jun 20107:00 amRNSFinal Results
2nd Jun 20107:00 amRNSDistribution Agreement
29th Apr 20107:00 amRNSNotice of preliminary results and trading update
28th Apr 20107:00 amRNSField trial results
31st Mar 20103:30 pmRNSTotal Voting Rights
29th Mar 20102:46 pmRNSHolding(s) in Company
29th Mar 20102:45 pmRNSHolding(s) in Company
29th Mar 20102:30 pmRNSHolding(s) in Company
12th Mar 201011:15 amRNSResult of General Meeting
25th Feb 20107:00 amRNSIssue of Equity
8th Feb 20107:00 amRNSArysta agreement
3rd Feb 20107:00 amRNSPiNT study results
18th Jan 20107:00 amRNSFinalist at 2010 Grower of the Year Awards
6th Jan 20103:15 pmRNSDirectorate Change
6th Jan 201012:40 pmRNSChange of Adviser
7th Dec 20097:00 amRNSHalf Yearly Report
1st Dec 200911:31 amRNSFurther Field Trial Results
22nd Oct 20097:00 amRNSAward of EU research grant
28th Sep 20097:00 amRNSTrading Statement
10th Sep 200910:36 amRNSHolding(s) in Company
10th Sep 200910:32 amRNSHolding(s) in Company
7th Sep 20098:31 amRNSNew Scientific Advisory Board Announcement
13th Aug 20098:41 amRNSSuccessful Application to Join Committee
6th Aug 20093:58 pmRNSGrant of Options
3rd Aug 20095:15 pmRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
3rd Aug 20099:50 amRNSHolding(s) in Company
31st Jul 200912:00 pmRNSTotal Voting Rights
30th Jul 200910:20 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.